ReviewZeitschrift fur Rheumatologie2011
[Treat-to-target from the perspective of office-based rheumatology].
Review in Zeitschrift fur Rheumatologie, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force.Annals of the rheumatic diseases · 2018Guideline
- Management of rheumatoid arthritis in Poland - where daily practice might not always meet evidence-based guidelines.Archives of medical science : AMS · 2021Article
- [Special treatment in rheumatology-cross-sectoral quality-oriented selective contracts].Zeitschrift fur Rheumatologie · 2019Review
- Residual disease activity and treatment adjustments in psoriatic arthritis in current clinical practice.Arthritis research & therapy · 2017Observational
- Improving patient flow of people with rheumatoid arthritis has the potential to simultaneously improve health outcomes and reduce direct costs.BMC musculoskeletal disorders · 2017Article
- DAS steered therapy in clinical practice; cross-sectional results from the METEOR database.BMC musculoskeletal disorders · 2016Article
- Article
- Quality of care of rural rheumatoid arthritis patients in Austria.Wiener klinische Wochenschrift · 2014Article
- Prioritizing the patient: optimizing therapy in rheumatoid arthritis. Results of a patient questionnaire in northern Germany.Open access rheumatology : research and reviews · 2013Article
- [Is treat to target compatible with health insurance and health insurance funds?].Zeitschrift fur Rheumatologie · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of evidence-based treat-to-target (T2T) recommendations alleviates decision-making for the rheumatologist and simultaneously promises substantial improvement of outcome for rheumatoid arthritis (RA) patients. For the office-based rheumatologist in Germany, however, implementation of T2T recommendations contains several difficulties. Limitations arise as a result of an insufficient number of rheumatologists as well as a lack of adequate remuneration both resulting in a lack of time for the individual RA patient. Furthermore budget limitations hinder the appropriate use of antirheumatic drugs and insofar counteract treating to the target of remission. Establishment of selective contracts for rheumatologists by health insurance funds might reduce many of these problems in future for the office-based rheumatologist in Germany.
Indexed as
Identifiers
21979318What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.